According to the new report of the SCIMAGO database in year 6, Iran has gained a special place in the number of scientific articles in the number of scientific articles, according to the new report of the SCIMAGO. Iran is ranked first among the countries of the region, with Türkiye, Saudi Arabia and Egypt in the next place. These statistics show Iran’s dramatic progress in science and technology.
It was a turning point in Iran’s biotechnology development from 1 to 5 years. During this period, Iran became a purely researcher from a scholarly producer of knowledge -based products and entry into global markets. Institutions such as the headquarters of science, biological technologies and stem cells played a key supportive role in the fledgling industry. Academic research went beyond the article and thesis and entered the commercialization phase, indicating a link between science and economics to meet the needs of the country.
Production of “Interferon Alpha” by Iranian experts
The production of interferon alpha, the first Iranian biotechnology drug to treat hepatitis, took place during this period, which is an important step in the country’s pharmaceutical self -sufficiency.
With the increase in the publication of extensive articles and support, Iran has made significant improvements in the field of biotechnology and health in the field of biotechnology and health, and the eighth world rank in the field of rehabilitation medicine. Iran has ranked fifth in Asia and ranked first in the region by producing more than 5 biotechnology -based products in the fields of medicine, agriculture, industry and environment.
These achievements represent the mass production of advanced and vital products by domestic experts and promise a bright future for the Iranian knowledge -based industry.
(Tagstotranslate) Vice President of Technology and Economics of Presidential Knowledge Based (T) Knowledge -Based Companies (T) Biotechnology
RCO NEWS




